Yüklüyor......

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?

Treatment responses to imatinib vary among patients with chronic myeloid leukemia (CML), and definitions of treatment failure and suboptimal response have been published. This article discusses monitoring and treatment of patients with CML after failure of or suboptimal response to imatinib therapy....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jabbour, Elias, Cortes, Jorge E., Kantarjian, Hagop M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mayo Foundation for Medical Education and Research 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2664587/
https://ncbi.nlm.nih.gov/pubmed/19181650
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!